BR9607612A - Terapia de combinaç o de inibidor de enzima de conversão de angiotensina quantidade de reduzido efeito colateral de antagonista da aldosterona e diurético par tratamento de doenças cardiovasculares - Google Patents
Terapia de combinaç o de inibidor de enzima de conversão de angiotensina quantidade de reduzido efeito colateral de antagonista da aldosterona e diurético par tratamento de doenças cardiovascularesInfo
- Publication number
- BR9607612A BR9607612A BR9607612A BR9607612A BR9607612A BR 9607612 A BR9607612 A BR 9607612A BR 9607612 A BR9607612 A BR 9607612A BR 9607612 A BR9607612 A BR 9607612A BR 9607612 A BR9607612 A BR 9607612A
- Authority
- BR
- Brazil
- Prior art keywords
- diuretic
- treatment
- side effect
- combination therapy
- cardiovascular diseases
- Prior art date
Links
- 239000005541 ACE inhibitor Substances 0.000 title 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 title 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 239000002170 aldosterone antagonist Substances 0.000 title 1
- 229940083712 aldosterone antagonist Drugs 0.000 title 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
- 239000002934 diuretic Substances 0.000 title 1
- 230000001882 diuretic effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38685895A | 1995-02-10 | 1995-02-10 | |
| PCT/US1996/001764 WO1996024372A2 (en) | 1995-02-10 | 1996-02-09 | Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9607612A true BR9607612A (pt) | 1998-06-09 |
Family
ID=23527363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9607612A BR9607612A (pt) | 1995-02-10 | 1996-02-09 | Terapia de combinaç o de inibidor de enzima de conversão de angiotensina quantidade de reduzido efeito colateral de antagonista da aldosterona e diurético par tratamento de doenças cardiovasculares |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP0808171A2 (pt) |
| JP (1) | JPH10513472A (pt) |
| KR (1) | KR19980702100A (pt) |
| AU (1) | AU4866196A (pt) |
| BR (1) | BR9607612A (pt) |
| CA (1) | CA2212712A1 (pt) |
| NZ (2) | NZ510572A (pt) |
| WO (1) | WO1996024372A2 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA003782B1 (ru) * | 1998-11-06 | 2003-08-28 | Дж.Д.Сирл Энд Ко. | Комбинированная терапия с применением ингибитора фермента конверсии ангиотензина и антагониста альдостерона для снижения заболеваемости и смертности при сердечно-сосудистых заболеваниях |
| US20010039262A1 (en) * | 2000-04-26 | 2001-11-08 | Balaji Venkataraman | Methods and compositions for the treatment of cardiac indications |
-
1996
- 1996-02-09 KR KR1019970705495A patent/KR19980702100A/ko not_active Ceased
- 1996-02-09 CA CA002212712A patent/CA2212712A1/en not_active Abandoned
- 1996-02-09 EP EP96904600A patent/EP0808171A2/en not_active Withdrawn
- 1996-02-09 EP EP01128866A patent/EP1201248A3/en not_active Withdrawn
- 1996-02-09 JP JP8524442A patent/JPH10513472A/ja not_active Abandoned
- 1996-02-09 NZ NZ510572A patent/NZ510572A/xx unknown
- 1996-02-09 BR BR9607612A patent/BR9607612A/pt not_active Application Discontinuation
- 1996-02-09 NZ NZ302578A patent/NZ302578A/en unknown
- 1996-02-09 WO PCT/US1996/001764 patent/WO1996024372A2/en not_active Ceased
- 1996-02-09 AU AU48661/96A patent/AU4866196A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0808171A2 (en) | 1997-11-26 |
| AU4866196A (en) | 1996-08-27 |
| NZ302578A (en) | 2001-05-25 |
| WO1996024372A3 (en) | 1996-09-26 |
| CA2212712A1 (en) | 1996-08-15 |
| KR19980702100A (ko) | 1998-07-15 |
| EP1201248A3 (en) | 2002-05-08 |
| EP1201248A2 (en) | 2002-05-02 |
| JPH10513472A (ja) | 1998-12-22 |
| WO1996024372A2 (en) | 1996-08-15 |
| NZ510572A (en) | 2002-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT936908E (pt) | Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) | |
| NO972972D0 (no) | Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse | |
| HUP0104249A3 (en) | Pharmaceutical composition for combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease | |
| AU3000297A (en) | Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy | |
| AP2002002540A0 (en) | Inhibitors of interleukin-1b converting enzyme | |
| CY2006007I2 (el) | Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας | |
| EP1009404A4 (en) | PROCESS FOR TREATING INFLAMMATION OR INFLAMMATORY DISEASES USING POLY-ADP RIBOSE POLYMERASE INHIBITORS | |
| HUP9801989A3 (en) | Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application | |
| FI972919A7 (fi) | Indolijohdannaisia jotka ovat käyttökelpoisia osteoporoosin hoidossa | |
| PL321680A1 (en) | Derivatives of proline useful as inhibitors of human leucocytes elastase | |
| EP1382351B8 (en) | Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease | |
| AU7042796A (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases | |
| WO1999057133A3 (en) | Inhibitors of nf-kb activation | |
| BR9607612A (pt) | Terapia de combinaç o de inibidor de enzima de conversão de angiotensina quantidade de reduzido efeito colateral de antagonista da aldosterona e diurético par tratamento de doenças cardiovasculares | |
| ATE236653T1 (de) | Kombination in feste dosiermenge von angiotensin- converting-enzyme-hemmern mit calcium-kanal antagonisten zur behandlung von herz- kreislauferkrankungen | |
| AU6281298A (en) | Use of lofexidine in the treatment of behavioral disorders | |
| ZA969586B (en) | The use of cholinesterase inhibitors in the treatment of xerostomia | |
| AU7688998A (en) | Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema | |
| AU2003202461A1 (en) | Combination therapy of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist for treatment of cardiovascular disease | |
| AU8049098A (en) | Composition and methods for the treatment of inflammatory diseases | |
| AU2003202486A1 (en) | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure | |
| AU6920398A (en) | Medicament for preventive and therapeutic treatment of inflammatory diseas es | |
| GB2318057A (en) | Treatment of nocturnal polyuria using an ace inhibitor in combination with a diuretic | |
| BA95039A (bs) | Set za prevenciju i terapiju bolne menstruacije | |
| HK1019854A (en) | Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO DE ACORDO COM O ART. 8O DA LPI. |